Commission Approves Final Consent Order in Matter of Allergan/Inamed

For Your Information

Commission approval of final consent order: Following a public comment period, the Commission has approved the issuance of a final consent order in the matter concerning Allergan, Inc.’s acquisition of Inamed Corporation. The vote to approve the final order was 4-0, with Commissioner J. Thomas Rosch recused. Copies are available now on the FTC’s Web site as a link to this press release. (FTC File No. 061-0031; the staff contact is James E. Southworth, Bureau of Competition, 202-326-2822.)

Copies of the documents mentioned in this release are available from the FTC’s Web site at http://www.ftc.gov and from the FTC’s Consumer Response Center, Room 130, 600 Pennsylvania Avenue, N.W., Washington, DC 20580. Call toll-free: 1-877-FTC-HELP.

Contact Information

Media Contact:
FTC Office of Public Affairs
202-326-2180